ALKERMES reported $-30136000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Acadia Pharmaceuticals ACAD:US $ -34.01M 79.04M
Acorda Therapeutics ACOR:US $ -46.68M 22.16M
Amgen AMGN:US $ 1317M 159M
Biogen BIIB:US $ 1058M 754.2M
Biomarin Pharmaceutical BMRN:US $ 27.66M 93.13M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Bristol Myers Squibb BMY:US $ 1421M 143M
Eli Lilly And LLY:US $ 952.5M 950.4M
Gilead Sciences GILD:US $ 1144M 1125M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Horizon Pharma HZNP:US $ 60.97M 143.29M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
JAZZ PHA JAZZ:US $ 34.66M 33.02M
Johnson & Johnson JNJ:US $ 4814M 335M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Merk MRK:US $ 3944M 366M
Minerva Neurosciences NERV:US $ -9.76M 11.54M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Neurocrine Biosciences NBIX:US $ -16.9M 30.8M
Otsuka Holdings 4578:JP Y 46497M 23240M
Pfizer PFE:US $ 9905M 2042M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Revance Therapeutics RVNC:US $ -64.34M 1.24M
Teva Pharmaceutical Industries TEVA:US $ -233M 722M
Vertex Pharmaceuticals VRTX:US $ 810.5M 48.4M